Unding, Farida .

HRN: 00-11-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/02/2023
03/08/2023
IV
500mg
OD
Respiratory Failure Prob Massive PE-intubated
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: